“…Thus, a non-invasive method to monitor the tumor initiation and growth, and to evaluate the therapeutic response is highly desirable (Grimm et al, 2003). Several in vivo imaging modalities, such as computed tomography (CT), positron-emission tomography (PET), optical imaging, and ultrasound, have been developed for assessing tumor size and/or volume in animal models (Cao et al, 2008;Ritelli et al, 2015;Wu et al, 2014). Among them, MRI provides a powerful tool for preclinical research due to several combined advantage (Partecke et al, 2011).…”